Comparison of Lanreotide Autogel® and Sandostatin LAR Depot in the Treatment of Clinical Symptoms Associated With Carcinoid Syndrome

This study has been terminated.
Information provided by:
Ipsen Identifier:
First received: September 22, 2004
Last updated: February 25, 2008
Last verified: February 2008
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: October 2004
  Estimated Primary Completion Date: No date given